Skip to main content
. 2015 Mar 20;20(4):695–703. doi: 10.1007/s00775-015-1255-5

Table 1.

Ru fraction [mol/mol(protein)] in ruthenated Tf or HSA produced after (1) incubation of NAMI-A, Tf and HSA at 1:1:1 molar ratio for 24 h in buffer; (2) incubation of HSA with 20 molar excess of NAMI-A, followed by purification by FPLC separation from free Ru species, and then mixed with Tf at 1:2 molar ratio

Model Molar ratio Ru/Tf Ru/HSA
(1) holo-Tf/HSA/NAMI-A 1:1:1 0.39 ± 0.08 0.65 ± 0.07
apo-Tf/HSA/NAMI 1:1:1 0.24 ± 0.09 0.56 ± 0.06
(2) (HSA/NAMI)/holo-Tf (1:1):2 0.31 ± 0.02 0.67 ± 0.03
(HSA/NAMI)/apo-Tf (1:1):2 0.23 ± 0.02 0.71 ± 0.05

Buffer conditions: 50 mM TRIS/HCl, 100 mM NaCl, 25 mM NaHCO3, pH 7.4, 37 °C